A comparision of the effect of sugammadex on the recovery period and postoperative residual block in young elderly and middle-aged elderly patients

dc.contributor.authorYazar, Emine
dc.contributor.authorYılmaz, Canan
dc.contributor.authorKarasu, Derya
dc.contributor.authorApaydın, Yılmaz
dc.contributor.authorSayan, Halil Erkan
dc.contributor.buuauthorBilgin, Hülya
dc.contributor.buuauthorBayraktar, Selcan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Anesteziyoloji ve Reanimasyon Anabilim Dalı.tr_TR
dc.contributor.orcid0000-0001-6639-5533tr_TR
dc.contributor.researcheridA-7338-2016tr_TR
dc.contributor.scopusid6701663354tr_TR
dc.contributor.scopusid34879358300tr_TR
dc.date.accessioned2023-06-07T12:37:12Z
dc.date.available2023-06-07T12:37:12Z
dc.date.issued2015-10-20
dc.descriptionBu çalışma, 20-24 Kasım 2013 tarihlerinde Antalya[Türkiye]’da düzenlenen 47. Congress of Turkish Anesthesiology & Reanimation Congress (TARK) Kongresi‘nde bildiri olarak sunulmuştur.tr_TR
dc.description.abstractBackground: The importance of the characteristics of anesthesia and postoperative residual curarization (PORC) in the elderly population should be a growing concern in this century. Aims: To investigate the effect of sugammadex on the duration of the recovery from neuromuscular blocking agents and postoperative residual curarization in the young elderly and middle-aged elderly patients who underwent elective laparoscopic cholecystectomy, followed by a train of four (TOF) watch monitorization. Study Design: Prospective clinical trial study. Methods: Sixty patients over the age of 65 with American Society of Anesthesiologists I-III were divided into two groups according to their age (65-74 years old and >= 75 years old). Patients received sugammadex (2.0 mg/kg iv) at the reappearance of the second twitch of the TOF as an agent for reversal of neuromuscular blockage at the end of surgery. Patients were extubated at the time of TOF >= 0.9. The patients' TOF responses were evaluated with regards to PORC in at the 5th minute and were followed up for one hour in the recovery room. Reintubation was applied for those patients who developed PORC and had peripheric oxygen saturation <90% despite being given 6 L oxygen per min with a face mask. Results: The onset time of neuromuscular blocking agent and time from T-2 to achieve TOF ratio 90% (the duration of sugammadex effect) or over were found to be longer in the middle-aged elderly group than in the young elderly group. A statistically significant relationship was found between age and the duration of TOF ratio to reach 0.9 in the same direction. The PORC incidence and rate of reintubation were found to be 1.7% in all patients. Conclusion: In our opinion, it is necessary to remember that the duration of sugammadex effect on the recovery period is prolonged for patients who are aged >= 75 years compared to patients aged between 65-74 years.en_US
dc.identifier.citationYazar, E. vd. (2016). "A comparision of the effect of sugammadex on the recovery period and postoperative residual block in young elderly and middle-aged elderly patients". Balkan Medical Journal, 33(2), 181-187.tr_TR
dc.identifier.endpage187tr_TR
dc.identifier.issn2146-3123
dc.identifier.issn2146-3131
dc.identifier.issue2tr_TR
dc.identifier.pubmed27403387tr_TR
dc.identifier.scopus2-s2.0-84963555175tr_TR
dc.identifier.startpage181tr_TR
dc.identifier.urihttps://doi.org/10.5152/balkanmedj.2016.16383
dc.identifier.urihttp://www.balkanmedicaljournal.org/uploads/pdf/pdf_BMJ_147.pdf
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924962/
dc.identifier.urihttp://hdl.handle.net/11452/32964
dc.identifier.volume33tr_TR
dc.identifier.wos000375056600009
dc.indexed.pubmedPubMeden_US
dc.indexed.scopusScopusen_US
dc.indexed.trdizinTrDizintr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherGalenos Yayıncılıktr_TR
dc.relation.collaborationSanayitr_TR
dc.relation.journalBalkan Medical Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGeneral & internal medicineen_US
dc.subjectElderlyen_US
dc.subjectPostoperative residual curarizationen_US
dc.subjectReintubationen_US
dc.subjectSugammadexen_US
dc.subjectInduced neuromuscular blockadeen_US
dc.subjectSurgical-patientsen_US
dc.subjectRocuroniumen_US
dc.subjectDurationen_US
dc.subjectReversalen_US
dc.subjectPharmacokineticsen_US
dc.subjectParalysisen_US
dc.subjectDrugsen_US
dc.subject.emtreeSugammadexen_US
dc.subject.emtreeAgeen_US
dc.subject.emtreeAgeden_US
dc.subject.emtreeAllergyen_US
dc.subject.emtreeAnesthesiology monitoring deviceen_US
dc.subject.emtreeAnesthetic recoveryen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBradycardiaen_US
dc.subject.emtreeBronchospasmen_US
dc.subject.emtreeCholecystectomyen_US
dc.subject.emtreeControlled clinical trialen_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeExtubationen_US
dc.subject.emtreeFace masken_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeFollow upen_US
dc.subject.emtreeHeart arrhythmiaen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHypotensionen_US
dc.subject.emtreeIntubationen_US
dc.subject.emtreeMajor clinical studyen_US
dc.subject.emtreeMaleen_US
dc.subject.emtreeNauseaen_US
dc.subject.emtreeNeuromuscular blockingen_US
dc.subject.emtreeNeuromuscular monitoringen_US
dc.subject.emtreeNeuromuscular transmissionen_US
dc.subject.emtreeOxygen saturationen_US
dc.subject.emtreePostoperative residual curarizationen_US
dc.subject.emtreeReintubationen_US
dc.subject.emtreeVomitingen_US
dc.subject.scopusSugammadex; Neuromuscular Blocking; Rocuroniumen_US
dc.subject.wosMedicine, general & internalen_US
dc.titleA comparision of the effect of sugammadex on the recovery period and postoperative residual block in young elderly and middle-aged elderly patientsen_US
dc.typeArticle
dc.wos.quartileQ3en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Yazar_vd_2016_PDF.pdf
Size:
437.63 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: